TICKERNOMICS Sign up
Last Update: 2024-03-28 02:09:56
Medpace Holdings Inc. ( MEDP ) https://www.medpace.com
402.75USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
MEDP
121.88%
SPY
32.74%
MEDP
142.58%
SPY
92.93%
MEDP
582.97%
SPY
224.41%
MEDP
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
12385.49
12304.52
0.15
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
45.34
6.95
22.16
4.63
0.00
34.24
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
17.24
27.04
19.12
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
9.7904
35.32
53.04
1.48
Other Earnings and Cash Flow Stats:
Medpace Holdings Inc. ( MEDP ) Net Income TTM ($MM) is 278.14
Medpace Holdings Inc. ( MEDP ) Operating Income TTM ($MM) is 325.37
Medpace Holdings Inc. ( MEDP ) Owners' Earnings Annual ($MM) is 386.34
Medpace Holdings Inc. ( MEDP ) Current Price to Owners' Earnings ratio is 32.06
Medpace Holdings Inc. ( MEDP ) EBITDA TTM ($MM) is 355.54
Medpace Holdings Inc. ( MEDP ) EBITDA Margin is 19.12%
Capital Allocation:
Medpace Holdings Inc. ( MEDP ) has paid 0.00 dividends per share and bought back 2.918708 million shares in the past 12 months
Medpace Holdings Inc. ( MEDP ) has increased its debt by 6.348 million USD in the last 12 months
Capital Structure:
Medpace Holdings Inc. ( MEDP ) Interest-bearing Debt ($MM) as of last quarter is 164
Medpace Holdings Inc. ( MEDP ) Annual Working Capital Investments ($MM) are -89
Medpace Holdings Inc. ( MEDP ) Book Value ($MM) as of last quarter is 558
Medpace Holdings Inc. ( MEDP ) Debt/Capital as of last quarter is 29%
Other Balance Sheet Stats:
Medpace Holdings Inc. ( MEDP ) has 245 million in cash on hand as of last quarter
Medpace Holdings Inc. ( MEDP ) has 925 million of liabilities due within 12 months, and long term debt 55 as of last quarter
Medpace Holdings Inc. ( MEDP ) has 30 common shares outstanding as of last quarter
Medpace Holdings Inc. ( MEDP ) has 0 million USD of preferred stock value
Academic Scores:
Medpace Holdings Inc. ( MEDP ) Altman Z-Score is 8.14 as of last quarter
Medpace Holdings Inc. ( MEDP ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
Medpace Holdings Inc. ( MEDP ) largest shareholder is owning shares at 0.00 ($MM) value
BURWIG SUSAN E(an insider) Sold 102 shares of Medpace Holdings Inc. ( MEDP ) for the amount of $41106.00 on 2024-03-15
44.50% of Medpace Holdings Inc. ( MEDP ) is held by insiders, and 84.39% is held by institutions
Medpace Holdings Inc. ( MEDP ) went public on 2016-08-11
Other Medpace Holdings Inc. ( MEDP ) financial metrics:
FCF:405.00
Unlevered Free Cash Flow:379.62
EPS:9.18
Operating Margin:17.24
Gross Profit Margin:27.04
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:50.49
Beta:1.48
Buffet's Owners Earnings:386.34
Price to Owner's Earnings:32.06
About Medpace Holdings Inc. ( MEDP ) :
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.